$14.98
0.463.17%
At close: -
$15.13
0.150.99%
After Hours: May 23, 7:59 PM EDT
Comments
Loading...
ARS Pharmaceuticals Insider Trading Activity | NASDAQ:SPRY | Benzinga
Track the latest ARS Pharmaceuticals insider trading activity. Stay informed on recent buys, sells, and market impact for ARS Pharmaceuticals stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are ARS Pharmaceuticals Inc Insiders Doing?
At ARS Pharmaceuticals Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 2.97K shares worth $893.51K, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On May 22, 2025, Alexander Fitzpatrick, the company's CHIEF LEGAL OFFICER sold 2.97K shares for $9.84 each.
Ownership Statistics for ARS Pharmaceuticals Inc
Shares Outstanding
98.214M
Insider Shares Owned
8.215M
Insider Percentage Owned
8.37%
Institutional Shares Held
23.482M
Institutional Percentage Held
23.9%
| May 22, 2025 | Alexander Fitzpatrick | CHIEF LEGAL OFFICER | -2.97K | $9.84 | -$893.51K | SELL | -3.21% | 89.61K | May 20 | View |
| May 22, 2025 | BRENT SAUNDERS | — | 0.00 | $7.63 | -$1.59M | SELL-OPTIONS | 0.00% | 0.00 | May 20 | View |
| May 22, 2025 | Kathleen Scott | CHIEF FINANCIAL OFFICER | 0.00 | $7.80 | -$630.16K | SELL-OPTIONS | 0.00% | 15.67K | May 20 | View |
| Apr 08, 2025 | Laura Shawver | — | 0.00 | $8.58 | -$372.56K | SELL-OPTIONS | 0.00% | 210.35K | Apr 07 | View |
| Mar 21, 2025 | Eric Karas | CHIEF COMMERCIAL OFFICER | 0.00 | $7.75 | -$125.00K | SELL-OPTIONS | 0.00% | 7.70K | Mar 20 | View |
| Mar 07, 2025 | Laura Shawver | — | 0.00 | $8.03 | -$317.95K | SELL-OPTIONS | 0.00% | 210.35K | Mar 05 - Mar 06 | View |
| Feb 04, 2025 | Laura Shawver | — | 0.00 | $8.43 | -$388.47K | SELL-OPTIONS | 0.00% | 210.35K | Feb 03 | View |
| Jan 07, 2025 | Laura Shawver | — | 0.00 | $7.13 | -$397.56K | SELL-OPTIONS | 0.00% | 210.35K | Jan 06 | View |
| Dec 19, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100.00K | $11.67 | -$1.17M | SELL | -1.81% | 5.43M | Dec 17 | View |
| Dec 19, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100.00K | $11.67 | -$1.17M | SELL | -2.16% | 4.53M | Dec 17 | View |
| Dec 13, 2024 | Justin Chakma | CHIEF BUSINESS OFFICER | 0.00 | $6.59 | -$1.63M | SELL-OPTIONS | 0.00% | 136.38K | Dec 12 - Dec 13 | View |
| Dec 13, 2024 | Brian Dorsey | CHIEF OPERATING OFFICER | 0.00 | $6.49 | -$468.26K | SELL-OPTIONS | 0.00% | 6.02K | Dec 11 - Dec 12 | View |
| Dec 12, 2024 | Justin Chakma | CHIEF BUSINESS OFFICER | 0.00 | $7.00 | -$615.63K | SELL-OPTIONS | 0.00% | 136.38K | Dec 10 | View |
| Dec 11, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100.00K | $13.16 | -$1.32M | SELL | -1.79% | 5.48M | Dec 10 | View |
| Dec 11, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100.00K | $13.16 | -$1.32M | SELL | -2.14% | 4.58M | Dec 10 | View |
| Dec 06, 2024 | Justin Chakma | CHIEF BUSINESS OFFICER | 0.00 | $7.48 | -$1.92M | SELL-OPTIONS | 0.00% | 136.38K | Dec 04 - Dec 06 | View |
| Dec 04, 2024 | Justin Chakma | CHIEF BUSINESS OFFICER | 0.00 | $7.13 | -$1.13M | SELL-OPTIONS | 0.00% | 136.38K | Dec 02 - Dec 03 | View |
| Dec 04, 2024 | Laura Shawver | — | 0.00 | $7.72 | -$2.29M | SELL-OPTIONS | 0.00% | 210.35K | Dec 02 - Dec 04 | View |
| Dec 04, 2024 | Eric Karas | CHIEF COMMERCIAL OFFICER | 0.00 | $7.77 | -$125.42K | SELL-OPTIONS | 0.00% | 5.69K | Dec 02 - Dec 04 | View |
| Nov 27, 2024 | Justin Chakma | CHIEF BUSINESS OFFICER | -100.00K | $14.12 | -$1.41M | SELL | -42.30% | 136.38K | Nov 25 - Nov 27 | View |
| Nov 21, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100.00K | $13.95 | -$1.39M | SELL | -2.12% | 4.61M | Nov 19 | View |
| Nov 21, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100.00K | $13.95 | -$1.39M | SELL | -1.78% | 5.51M | Nov 19 | View |
| Nov 14, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100.00K | $16.85 | -$1.68M | SELL | -1.77% | 5.56M | Nov 12 | View |
| Nov 14, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100.00K | $16.85 | -$1.68M | SELL | -2.10% | 4.66M | Nov 12 | View |
| Nov 13, 2024 | James FlynnDEERFIELD MANAGEMENT COMPANY LP SERIES CDeerfield Mgmt III LPDeerfield Private Design Fund III LPDeerfield Mgmt IV LPDeerfield Private Design Fund IV LP | 10% OWNER | -563.27K | $18.01 | -$10.14M | SELL | -9.68% | 5.26M | Nov 11 - Nov 12 | View |
| Oct 17, 2024 | Kathleen Scott | CHIEF FINANCIAL OFFICER | 0.00 | $8.75 | -$181.25K | SELL-OPTIONS | 0.00% | 13.20K | Oct 16 | View |
| Oct 17, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100.00K | $14.88 | -$1.49M | SELL | -1.75% | 5.61M | Oct 15 | View |
| Oct 17, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100.00K | $14.88 | -$1.49M | SELL | -2.08% | 4.71M | Oct 15 | View |
| Oct 10, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100.00K | $13.83 | -$1.38M | SELL | -1.73% | 5.66M | Oct 08 | View |
| Oct 10, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100.00K | $13.83 | -$1.38M | SELL | -2.06% | 4.76M | Oct 08 | View |
| Sep 19, 2024 | Eric Karas | CHIEF COMMERCIAL OFFICER | 0.00 | $7.75 | -$125.00K | SELL-OPTIONS | 0.00% | 5.69K | Sep 18 | View |
| Sep 19, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100.00K | $12.93 | -$1.29M | SELL | -1.72% | 5.71M | Sep 17 | View |
| Sep 19, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100.00K | $12.93 | -$1.29M | SELL | -2.04% | 4.81M | Sep 17 | View |
| Sep 12, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100.00K | $11.50 | -$1.15M | SELL | -1.71% | 5.76M | Sep 10 | View |
| Sep 12, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100.00K | $11.50 | -$1.15M | SELL | -2.02% | 4.86M | Sep 10 | View |
| Aug 28, 2024 | Peter A Thompson | DIRECTOR | -83.69K | $13.00 | -$1.09M | SELL | -1.03% | 8.02M | Aug 26 | View |
| Aug 28, 2024 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLCORBIMED CAPITAL LLC | DIRECTOR | -83.69K | $13.00 | -$1.09M | SELL | -1.03% | 8.02M | Aug 26 | View |
| Aug 23, 2024 | Peter A Thompson | DIRECTOR | -868.68K | $13.24 | -$11.50M | SELL | -9.68% | 8.10M | Aug 21 - Aug 23 | View |
| Aug 23, 2024 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLCORBIMED CAPITAL LLC | DIRECTOR | -868.68K | $13.24 | -$11.50M | SELL | -9.68% | 8.10M | Aug 21 - Aug 23 | View |
| Aug 21, 2024 | Brian Dorsey | CHIEF OPERATING OFFICER | 0.00 | $7.82 | -$718.00K | SELL-OPTIONS | 0.00% | 6.02K | Aug 20 | View |
| Aug 21, 2024 | Eric Karas | CHIEF COMMERCIAL OFFICER | 0.00 | $7.75 | -$125.00K | SELL-OPTIONS | 0.00% | 5.69K | Aug 19 | View |
| Aug 21, 2024 | Kathleen Scott | CHIEF FINANCIAL OFFICER | 0.00 | $8.75 | -$181.25K | SELL-OPTIONS | 0.00% | 13.20K | Aug 20 | View |
| Aug 21, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100.00K | $15.03 | -$1.50M | SELL | -1.69% | 5.81M | Aug 20 | View |
| Aug 21, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100.00K | $15.03 | -$1.50M | SELL | -2.00% | 4.91M | Aug 20 | View |
| Aug 15, 2024 | Brian Dorsey | CHIEF OPERATING OFFICER | 0.00 | $6.82 | -$370.80K | SELL-OPTIONS | 0.00% | 6.02K | Aug 13 | View |
| Aug 15, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100.00K | $12.48 | -$1.25M | SELL | -1.68% | 5.86M | Aug 13 | View |
| Aug 15, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100.00K | $12.48 | -$1.25M | SELL | -1.98% | 4.96M | Aug 13 | View |
| Jul 18, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100.00K | $11.40 | -$1.14M | SELL | -1.96% | 5.01M | Jul 16 | View |
| Jul 18, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100.00K | $11.40 | -$1.14M | SELL | -1.66% | 5.91M | Jul 16 | View |
| Jul 11, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100.00K | $9.62 | -$961.73K | SELL | -1.65% | 5.96M | Jul 09 | View |
| Jul 11, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100.00K | $9.62 | -$961.73K | SELL | -1.94% | 5.06M | Jul 09 | View |
| Jun 13, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100.00K | $9.14 | -$913.92K | SELL | -2.94% | 3.30M | Jun 11 - Jun 12 | View |
| Jun 13, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100.00K | $9.14 | -$913.92K | SELL | -2.94% | 3.30M | Jun 11 - Jun 12 | View |
| May 16, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100.00K | $9.05 | -$905.44K | SELL | -1.62% | 6.06M | May 14 - May 16 | View |
| May 16, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100.00K | $9.05 | -$905.44K | SELL | -1.90% | 5.16M | May 14 - May 16 | View |
| May 09, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100.00K | $9.34 | -$934.37K | SELL | -1.61% | 6.11M | May 07 | View |
| May 09, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100.00K | $9.34 | -$934.37K | SELL | -1.88% | 5.21M | May 07 | View |
| Apr 17, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100.00K | $9.28 | -$928.00K | SELL | -1.65% | 5.98M | Apr 16 | View |
| Apr 17, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100.00K | $9.28 | -$928.00K | SELL | -1.91% | 5.13M | Apr 16 | View |
| Apr 10, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100.00K | $9.28 | -$927.73K | SELL | -1.63% | 6.03M | Apr 09 | View |
| Apr 10, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100.00K | $9.28 | -$927.73K | SELL | -1.90% | 5.18M | Apr 09 | View |
| Mar 27, 2024 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah | DIRECTOR | 1.40M | $9.48 | $13.29M | BUY | 14.81% | 10.86M | Mar 25 - Mar 27 | View |
| Mar 26, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -97.61K | $9.12 | -$890.32K | SELL | -1.83% | 5.23M | Mar 22 - Mar 25 | View |
| Mar 26, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -97.61K | $9.12 | -$890.32K | SELL | -1.58% | 6.08M | Mar 22 - Mar 25 | View |
| Mar 21, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -2.39K | $9.03 | -$21.57K | SELL | -0.05% | 5.27M | Mar 19 - Mar 21 | View |
| Mar 21, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -2.39K | $9.03 | -$21.57K | SELL | -0.04% | 6.12M | Mar 19 - Mar 21 | View |
| Mar 15, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100.00K | $9.14 | -$913.68K | SELL | -2.60% | 3.75M | Mar 13 - Mar 15 | View |
| Mar 15, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100.00K | $9.14 | -$913.68K | SELL | -2.60% | 3.75M | Mar 13 - Mar 15 | View |
| Mar 01, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -3.78K | $9.02 | -$34.10K | SELL | -0.06% | 5.87M | Feb 29 | View |
| Mar 01, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -3.78K | $9.02 | -$34.10K | SELL | -0.08% | 5.02M | Feb 29 | View |
| Feb 28, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -99.48K | $9.02 | -$897.37K | SELL | -1.66% | 5.88M | Feb 26 - Feb 28 | View |
| Feb 28, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -99.48K | $9.02 | -$897.37K | SELL | -1.94% | 5.03M | Feb 26 - Feb 28 | View |
| Oct 02, 2023 | Alexander Fitzpatrick | CHIEF LEGAL OFFICER | 86.26K | $3.71 | $319.95K | BUY | 2905.29% | 89.23K | Sep 28 - Sep 29 | View |
| Sep 25, 2023 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah | DIRECTOR | 2.70M | $3.03 | $8.18M | BUY | 39.94% | 9.46M | Sep 21 | View |
| Sep 05, 2023 | Laura Shawver | DIRECTOR | 0.00 | $4.49 | -$643.52K | SELL-OPTIONS | 0.00% | 210.35K | Sep 01 | View |
| Aug 31, 2023 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah | DIRECTOR | 3.75M | $6.20 | $23.25M | BUY | 124.60% | 6.76M | Aug 29 | View |
| Aug 31, 2023 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLCORBIMED CAPITAL LLC | DIRECTOR | 500.00K | $6.20 | $3.10M | BUY | 5.90% | 8.97M | Aug 29 | View |
| Aug 31, 2023 | Peter A Thompson | DIRECTOR | 500.00K | $6.20 | $3.10M | BUY | 5.90% | 8.97M | Aug 29 | View |
| Aug 07, 2023 | Laura Shawver | DIRECTOR | 0.00 | $4.15 | -$259.33K | SELL-OPTIONS | 0.00% | 210.35K | Aug 03 - Aug 04 | View |
| Aug 03, 2023 | Laura Shawver | DIRECTOR | 0.00 | $4.20 | -$322.00K | SELL-OPTIONS | 0.00% | 210.35K | Aug 01 - Aug 02 | View |
| Jul 07, 2023 | Laura Shawver | DIRECTOR | 0.00 | $3.82 | -$45.12K | SELL-OPTIONS | 0.00% | 210.35K | Jul 07 | View |
| Jul 06, 2023 | Laura Shawver | DIRECTOR | 0.00 | $3.87 | -$474.70K | SELL-OPTIONS | 0.00% | 210.35K | Jul 03 - Jul 06 | View |
| Jun 02, 2023 | Laura Shawver | DIRECTOR | 0.00 | $4.06 | -$557.04K | SELL-OPTIONS | 0.00% | 210.35K | Jun 01 - Jun 02 | View |
| May 10, 2023 | Laura Shawver | DIRECTOR | -43.90K | $3.35 | -$653.58K | SELL | -17.27% | 210.35K | Nov 09 - May 09 | View |
| Dec 01, 2022 | Kathleen Scott | CHIEF FINANCIAL OFFICER | 8.25K | $6.24 | $51.51K | BUY | ∞ | 8.25K | Nov 29 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
